Ribonucleases and Immunoribonucleases as Potential Modalities of Anticancer Therapy

Review Data

o   Purpose and Significance of Study: This is a review of the potential role that ribonucleases and immunoribonucleases may play in cancer therapy in light of the rekindled interest in these agents.

 

o   Fit with Scope of Journal: The manuscript is of very high interest for the journal Drug and Drug Abuse.

 

o   The review thoroughly covers the various aspects related to the anticancer effect of ribonucleases and immunoribonucleases. The relevant literature is appropriately cited.

 

o   The minor errors (already corrected in the galley proof, except the highlighted one, which requires the author’s attention) are listed below –

 

·       Numerous words were spelled incorrectly throughout the text, e.g., trifluoperazine, immunodeficiency, genome, exhibit, equipped, K. pneumoniae, discovered, cytotoxicity, toxicity, predictable, reducing, facilitate, lymphoma, antibody, targeted, successfully, saline, molecule, presentation, prognosis, potent, tumorigenesis, expression, contains, treatment, demonstrated, conjugations, polymer, mesothelioma, delivered, increased, and release.

·       Words like “anticancer”, “antitumor”, “multidrug”, etc. must be written without hyphens in all places for consistency.

·       In the 2^nd sentence of the Abstract, “an” before amphibian must be removed, in the 4^th sentence of the 2^nd paragraph of the Introduction, “an” before “attractive” must be removed, and so on.

·       Incorrect form of words for singular/ plural number used, e.g., in the last sentence of the Abstract, “summarize” must be replaced with “summarizes”, in the 1^st sentence of the 1^st paragraph of the Introduction, “cell” must be replaced with “cells”, in the nest sentence, “operate” must be replaced with “operates”, and so on.

·       In the last sentence of the Abstract, “as” must be replaced with “and”.

·       Usage of incorrect prepositions, e.g., “on” must be replaced with “of” in the last sentence of the Abstract, “in” after “for” must be removed in the last sentence of the 3^rd paragraph of the Mechanisms of Cytotoxic Activity, “for” must be replaced with “on” in the 1^st sentence of the 1^st paragraph of the Antiviral Effect, and so on.

·       Certain unnecessary words must be removed, e.g., “occurred” in the 2^nd sentence of the Abstract, “of performed” in the 4^th sentence of the Bactericidal Activity, and so on.

·       Usage of incorrect tense of verbs, e.g., “modulate” must be replaced with “modulated” in the 3^rd sentence of the 4^th paragraph of the Targeted therapeutic RNases (immunoRNases), “worsens” must be replaced with “worsened” in the 1^st sentence of the next paragraph, and so on.

·       In the 1^st sentence of the 7^th paragraph of Targeted Therapeutic RNases (ImmunoRNases), “acts” must be replaced with “plays an”.

·       The meaning of a few parts is unclear because of incorrect construction, e.g., “sensitizing to radiotherapy effect of onconase” in the 1^st sentence of the last paragraph of Therapeutic Applications, “Following target of oncological…cancers. Connection onconase…efficacy RNase.”; thus, these must be rephrased.

·       Articles, e.g., “the” and commas were missing at several places in the text.

Author Info

Monika Kowalik Magdalena Witkowska Piotr Smolewski

Corresponding Author

Piotr Smolewski
Department of Experimental Hematology, Medical University of Lodz, Poland

Article Info

Article Type

Review Article

Publication history

Received: Tue 07, Jul 2020
Accepted: Wed 22, Jul 2020
Published: Thu 10, Sep 2020

Copyright

© 2023 Piotr Smolewski. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.DDA.2020.01.04